14 May 2013 14:12 [Source: ICIS news]
LONDON (ICIS)--Germany’s Evonik has formed a joint venture with US-based OPX Biotechnologies (OPXBIO) to developed bio-based specialty chemicals, it said on Tuesday.
The joint venture will use OPXBIO’s proprietary EDGE technology. EDGE, or "Efficiency Directed Genome Engineering", is a technology to develop bio-processes.
Financial, product or capacity details were not disclosed.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections